Based on extensive archival research and interviews with key figures, this text provides a comprehensive history of the consumption and control of cannabis in the UK.

Roger Roffman first discovered marijuana while serving as a US Army officer in Vietnam. From these seemingly innocuous beginnings, Roffman has been fascinated by marijuana, as a researcher, scholar, therapist, activist, and user. Ever since America’s youth first marched in opposition to the war in Vietnam, pot’s popularity has periodically ebbed and surged. Calls for greater, fewer, or no marijuana penalties also have swung on their own pendulum.From lobbying in Washington, to talking to doctors and nurses in oncology wards, and watching his brother struggle with addiction, Roffman has experienced the layered and complex relationship Americans have with marijuana first-hand. With one foot on each side of the fence, at times feeling at odds with both camps, Roffman is on a quest to challenge those who insist we think of marijuana as a weapon of mass destruction, as well as those who would have us see it as a harmless source of pleasure and relief.

Cannabis consumption, commerce, and control in global history, from the nineteenth century to the present day. This book gathers together authors from the new wave of cannabis histories that has emerged in recent decades. It offers case studies from Africa, Asia, the Americas, Europe, and the Middle East. It does so to trace a global history of the plant and its preparations, arguing that Western colonialism shaped and disseminated ideas in the nineteenth century that came to drive the international control regimes of the twentieth. More recently, the emergence of commercial interests in cannabis has been central to the challenges that have undermined that cannabis consensus. Throughout, the determination of people around the world to consume substances made from the plant has defied efforts to stamp them out and often transformed the politics and cultures of using them. These texts also suggest that globalization might have a cannabis history. The migration of consumers, the clandestine networks established to supply them, and international cooperation on control may have driven much of the interconnectedness that is a key feature of the contemporary world.

Thanks to its best-known use, any mention of cannabis tends to bring up jokes about the munchies or debates about marijuana and legalized drug use. But this not-so-innocent flowering plant was one of the first to be domesticated by humans, and it has been used in spiritual, therapeutic, and even punitive applications ever since—in addition to its more recreational purpose. Despite all the hoopla surrounding cannabis, however, we actually understand relatively little about it in the human and ecological past. In Cannabis, Chris Duvall explores the botanical and cultural history of one of our most widely distributed crops, presenting an even-handed look at this heady little plant. Providing a global historical geography of cannabis, Duvall discusses the manufacture of hemp and its role in rope-making, clothing, and paper, as well as cannabis’s use as oil and fuel. His focus, though, is on its most prevalent use: as a psychoactive drug. Without advocating for either the prohibition or legalization of the drug, Duvall analyzes a wide range of works to offer a better understanding of both stances and, moreover, the diversity of human-cannabis relationships across the world. In doing so, he corrects the overly simplistic portrayals of cannabis that have dominated discourse on the subject, arguing that we need to understand the big picture in order to improve how the plant is managed worldwide. Richly illustrated and highly accessible, Cannabis is an essential read to understand the rapidly evolving debate over the legalization of marijuana in the United States and other countries.

Cannabis Britannica explores the historical origins of the UK's legislation and regulations on cannabis preparations before 1928. It draws on published and unpublished sources from the seventeenth century onwards, from archives in the UK and India, to show how the history of cannabis and the British before the twentieth century was bound up with imperialism. James Mills argues that until the 1900s, most of the information and experience gathered by British sources were drawn from colonial contexts as imperial administrators governed and observed populations where use of cannabis was extensive and established. This is most obvious in the 1890s when British anti-opium campaigners in the House of Commons seized on the issue of Government of India excise duties on the cannabis trade in Asia in order to open up another front in their attacks on imperial administration. The result was that cannabis preparations became a matter of concern in Parliament which accordingly established the Indian Hemp Drugs Commission. The story in the twentieth century is of the momentum behind moves to include cannabis substances in domestic law and in international treaties. The latter was a matter of the diplomatic politics of imperialism, as Britain sought to defend its cannabis revenues in India against American and Egyptian interests. The domestic story focuses on the coming together of the police, the media, and the pharmaceutical industry to form misunderstandings of cannabis that forced it onto the Poisons Schedule despite the misgivings of the Home Office and of key medical professionals. The book is the first full history of the origins of the moments when cannabis first became subjected to laws and regulations in Britain.

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

Leading experts on the science, history, politics, medicine, and potential of America’s most popular recreational drug • With contributions by Andrew Weil, Michael Pollan, Lester Grinspoon, Allen St. Pierre (NORML), Tommy Chong, and others • Covers marijuana’s physiological and psychological effects, its medicinal uses, the complex politics of cannabis law, pot and parenting, its role in creativity, business, and spirituality, and much more Exploring the role of cannabis in medicine, politics, history, and society, The Pot Book offers a compendium of the most up-to-date information and scientific research on marijuana from leading experts, including Lester Grinspoon, M.D., Rick Doblin, Ph.D., Allen St. Pierre (NORML), and Raphael Mechoulam. Also included are interviews with Michael Pollan, Andrew Weil, M.D., and Tommy Chong as well as a pot dealer and a farmer who grows for the U.S. Government. Encompassing the broad spectrum of marijuana knowledge from stoner customs to scientific research, this book investigates the top ten myths of marijuana; its physiological and psychological effects; its risks; why joints are better than water pipes and other harm-reduction tips for users; how humanity and cannabis have co-evolved for millennia; the brain’s cannabis-based neurochemistry; the complex politics of cannabis law; its potential medicinal uses for cancer, AIDS, Alzheimer’s, multiple sclerosis, and other illnesses; its role in creativity, business, and spirituality; and the complicated world of pot and parenting. As legalization becomes a reality, this book candidly offers necessary facts and authoritative opinions in a society full of marijuana myths, misconceptions, and stereotypes.

When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines. With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation. While the historical literature has focused on cannabis as an illicit substance, Remedicalizing Cannabis considers the botanical product and its potential to yield medical applications. Investigating the remedicalization of cannabis, Taylor explores the process whereby boundaries shift between illicit drug and licit medicine. Basing her arguments on archival material from expert committees, researchers, and activists and in-depth interviews with key players, Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism. Remedicalizing Cannabis investigates the evolving tensions that have brought us to the current situation and demonstrates the role of history in understanding today’s debates about cannabis.

Focussing on the ways in which cannabis has been demonized, sacralized and normalized, Christopher Partridge analyses the complex and often difficult relationship Western societies have had with the plant since the nineteenth century. After an introduction to cannabis and its uses, the book discusses how and why it was constructed as a profane influence and a marker of deviance. It then examines the emergence of medicinal cannabis, showing how this has contributed to its normalization and even its sacralization. Finally, there is a discussion of sacred cannabis, which looks at its use within modern occultism, Rastafari and several cannabis churches. Overall, the book provides a cultural history of cannabis in the modern world, which exposes the underlying reasons for the various and changing attitudes to this popular psychoactive substance.

Cannabis is a genetically diverse plant that has been commodified for a variety of different purposes by many cultures throughout world history. For thousands of years, people have used its fiber, seed, and flowers to make rope and cloth, rig ships, feed people and livestock, concoct medicines, and alter states of consciousness. Until the nineteenth century, though, most Europeans and Americans were unaware of drug varieties of cannabis. The British encountered them in India and created western-style medicines that sold throughout the Atlantic world by the 1840s, but negative associations with Oriental intoxication and degeneracy sullied the plant’s reputation as a viable commodity. Now, after decades of transatlantic criminalization policies against cannabis in the twentieth century, it is making a comeback. In Commodifying Cannabis, Bradley J. Borougerdi traces the tangled histories of its use for fiber, medicine, and altered states of consciousness across the Atlantic world, focusing on the dynamic interplay between these three different cultural applications to explain why the plant has transformed so many times throughout history. The historical journey spans a vast geographical landscape and includes over three centuries of source material to illuminate the cultural foundations behind the myriad transformations cannabis has endured as a commodity in the Atlantic world.